# Heme Arginate in Cardiac Surgery Patients

> **NCT02142699** · PHASE2 · COMPLETED · sponsor: **University of Edinburgh** · enrollment: 20 (actual)

## Conditions studied

- Acute Kidney Injury

## Interventions

- **DRUG:** Heme arginate

## Key facts

- **NCT ID:** NCT02142699
- **Lead sponsor:** University of Edinburgh
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10-17
- **Primary completion:** 2015-10-16
- **Final completion:** 2015-11-16
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2024-09-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02142699

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02142699, "Heme Arginate in Cardiac Surgery Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02142699. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*